Paper Details
- Home
- Paper Details
Original Abstract of the Article :
The present study has been carried out on 50 patients admitted to C.C.U. for cardiovascular diseases of various ethiology (44 patients with ischemic heart disease) who required antiarrhythmic theory for different types of ventricular arrhythmias: monofocal ventricular extrasistoles greater than 6/mi...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/6169578
データ提供:米国国立医学図書館(NLM)
Ventricular Arrhythmias: A Desert of Irregular Heartbeats
Heart arrhythmias, like a sandstorm swirling within the heart, can disrupt the rhythm of life. This study compares the antiarrhythmic effectiveness of mexiletine and lidocaine in treating ventricular hyperkinetic arrhythmias. The researchers conducted a study with 50 patients experiencing different types of ventricular arrhythmias, randomly assigning them to receive either mexiletine or lidocaine. They then evaluated the effectiveness of each drug in controlling the arrhythmias.
Finding a Better Way to Tame the Desert of Arrhythmias
The study found that mexiletine was significantly more effective in controlling ventricular arrhythmias than lidocaine. This suggests that mexiletine might be a better choice for managing these heart rhythm disturbances. It's like finding a more effective camel to navigate the treacherous terrain of irregular heartbeats.
Navigating the Desert of Heart Health
This research provides valuable information for physicians treating ventricular arrhythmias, suggesting that mexiletine might be a more effective treatment option. This knowledge can help them make informed decisions about managing these heart rhythm disturbances and improving patient outcomes. It's like discovering a new oasis of knowledge in the desert of heart health, providing guidance for better care and treatment.
Dr.Camel's Conclusion
This research offers a new path through the desert of ventricular arrhythmias, highlighting the potential of mexiletine as a more effective treatment option. It's like discovering a new oasis of hope, offering a pathway to better heart health and a more stable rhythm of life.
Date :
- Date Completed 1981-12-21
- Date Revised 2013-11-21
Related Literature
Italian
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.